Fig 1.
The age-adjusted incidence of pancreatic acinar cell carcinoma during 2004–2016.
Table 1.
The clinicopathologic features of the patients with pancreatic acinar cell carcinoma.
Table 2.
The clinical features of the patients with pancreatic acinar cell carcinoma according to stratification by the summary stage.
Table 3.
Observed, expected and relative survival rates of pancreatic acinar cell carcinoma patients from 2004 to 2016.
Fig 2.
(A) Kaplan–Meier estimated overall survival (OS) for patients with pancreatic acinar cell carcinoma (ACC) in terms of age (p = 0.003), (B) Kaplan–Meier estimated OS for patients with pancreatic ACC in terms of summary stage (p<0.001 for both); (C). Kaplan–Meier estimated OS for patients with pancreatic ACC in terms of marital status (p = 0.448).
Fig 3.
Kaplan–Meier estimated overall survival for patients with pancreatic acinar cell carcinoma based on the summary stage.
(A-C): based on localized stage, A:surgery (p = 0.053), B: chemotherapy (p = 0.609), and C: radiotherapy (p = 0.729), (D-F): based on regional stage, D:surgery (p<0.001), E: chemotherapy (p = 0.041), F: radiotherapy (p = 0.369) (G-I) based on distant stage:G: surgery (p = 0.031), H: chemotherapy (p<0.001), I: radiotherapy (p = 0.365).
Table 4.
Univariate and multivariate regression analysis of overall survival in patients with pancreatic acinar cell carcinoma.